This study was performed to investigate the protective and therapeutic effects of
resveratrol (RES) against CdCl2-induced toxicity in rat testes. Seven
experimental groups of adult male rats were formulated as follows: A) controls+NS, B)
control+vehicle (saline solution of hydroxypropyl cyclodextrin), C) RES treated, D)
CdCl2+NS, E) CdCl2+vehicle, F) RES followed by CdCl2
and M) CdCl2 followed by RES. At the end of the protocol, serum levels of FSH,
LH and testosterone were measured in all groups, and testicular levels of TBARS and
superoxide dismutase (SOD) activity were measured. Epididymal semen analysis was
performed, and testicular expression of Bcl-2, p53 and Bax was assessed by RT-PCR. Also,
histopathological changes of the testes were examined microscopically. Administration of
RES before or after cadmium chloride in rats improved semen parameters including count,
motility, daily sperm production and morphology, increased serum concentrations of
gonadotropins and testosterone, decreased testicular lipid peroxidation and increased SOD
activity. RES not only attenuated cadmium chloride-induced testicular histopathology but
was also able to protect against the onset of cadmium chloride testicular toxicity.
Cadmium chloride downregulated the anti-apoptotic gene Bcl2 and upregulated the expression
of pro-apoptotic genes p53 and Bax. Resveratrol protected against and partially reversed
cadmium chloride testicular toxicity via upregulation of Bcl2 and downregulation of p53
and Bax gene expression. The antioxidant activity of RES protects against cadmium chloride
testicular toxicity and partially reverses its effect via upregulation of BCl2 and
downregulation of p53 and Bax expression.